- Our primary focus is targeted virotherapy, based on a fundamental mediator of cell immortalization in cancer
- Our goal: unlock the full potential of our virotherapy platform to treat a wide range of solid tumors, even immunologically cold tumor types
- Director, Clinical Development and Medical Affairs Strategy; NJ http://www.tseworldwide.com/cdma-strategy/
- Head of Clinical Development and Medical Affairs – NJ http://www.tseworldwide.com/head-of-clinical-development-and-medical-affairs-nj/
- Director, Clinical Development Operations; NJ http://www.tseworldwide.com/director-clinical-development-operations-nj/
please email CV and cover letter to jobs@tseworldwide.com